Epogin filed in chemotherapy setting in Japan
This article was originally published in Scrip
Executive Summary
Chugai's Epogin (epoetin beta) had been filed in Japan for use in chemotherapy-induced anaemia, an indication which will be key to propping up lacklustre sales of the Roche subsidiary's top product.